【摘要】 目的观察并验证精浊病湿热瘀阻证型的确立。方法选择精浊病湿热瘀阻证患者60例,随机分成治疗组及对照组。治疗组30例予清浊祛瘀汤,对照组30例予前列舒通胶囊。在第1次访视(治疗前)、第2次访视(治疗第2周最后(1±3)d)、第3次访视[治疗第4周最后(1±3)d]分别采用慢性前列腺炎症状评分(NIH-CPSI)、国际前列腺症状评分(IPSS)评价治疗组及对照组治疗效果并进行对比分析。结果治疗组与对照组治疗前NIH-CPSI及IPSS评分差异无统计学意义(P>0.05),治疗后差异有统计学意义(P <0.05),表明治疗组治疗效果优于对照组,临床有效。结论验证了精浊病湿热瘀阻证型的确立。更多还原

【Abstract】 Objective To observe and verify the establishment of syndrome type of dampness-heat stasis in turbidity disease. Methods60 cases of syndrome of dampness-heat stasis of turbidity disease were randomly divided into treatment group and control group.The treatment group of 30 cases was treated with Qingzhuo Quyu decoction. The control group of 30 cases was treated with Qianlie Shutong capsule. At the first visit(Before treatment), second visit(the last 1± 3 days of the second week of treatment), third visit(the last 1± 3 days of the 4 th week) adopt the USA National Institutes of health(NIH) respectively formulated symptom score of chronic prostatitis(CPSI), International Prostate Symptom Score(IPSS), to evaluate the therapeutic effect of treatment group and control group and make a comparative analysis. Results There was no statistically significant difference in NIH-CPSI and IPSS scores between the treatment group and the control group before treatment(P>0.05), and there was statistically significant difference after treatment(P<0.05), indicating that the treatment group was superior to the control group in treatment effect and was clinically effective. Conclusion The establishment of the syndrome of dampness-heat and stasis in fine turbid disease was verified.更多还原